The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.

Overview of attention for article published in Journal of Clinical Sleep Medicine, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 27 news outlets
blogs: 2 blogs

twitter: 28 X users
facebook: 1 Facebook page

Readers on

mendeley: 8 Mendeley

Summary News Blogs X Facebook

So far, Altmetric has seen 2 posts from 2 blogs.

Antidepressant improves upper airway stability in OSA

the limbic, 10 Oct 2022

Monotherapy with the norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea (OSA) severity. Until…

A new treatment for sleep apnea could be created using antidepressants

Interesting Engineering, 09 Oct 2022

Sleep apnea is a condition that affects almost a billion peopl

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.